Inventor

CHRISTOPHE TRATRAT

Inventor

SA

Overview

2023–2025

Patent span

Human necessities

Primary field (CPC A)

Patents· 102 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds43%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%

A61KPreparations for medical, dental or toiletry purposes11%

Y02ATechnologies for adaptation to climate change3%

PatentTitleYear

12,286,436Substituted pyrimido[4,5-b]indoles as CK2 inhibitors2025 12,269,8267H-pyrido[4',3':4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds as CK2 inhibitors2025 12,269,827Substituted pyrazino[1',2':1,5]pyrazolo[4,3-c][1,6]naphthyridines as CK2 inhibitors2025 12,258,345Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors2025 12,240,851Pyrido[3',4':4,5]pyrrolo[3,2-c]naphthyridine compounds as CK2 inhibitors2025 12,215,107Pyrazino[1',2':1,5]pyrazolo[4,3-c] [2,6] naphthyridine compounds as CK2 inhibitors2025 12,209,089Pyrimido[1',6': 1,5]pyrazolo[4,3-c] [2,7] naphthyridines as CK2 inhibitors2025 12,187,726Imidazo[1,5-a]pyrido[4,3-e]pyrazines as CK2 inhibitors2025 12,180,208Pyrazolo[1,5-c]pyrido[3,4-e]pyrimidines as CK2 inhibitors2024 12,180,218Substituted pyrimido[4,5-b]indoles as CK2 inhibitors2024 12,180,209Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 12,173,005Pyrimido[1',6':1,5]pyrazolo[4,3-b][1,7]naphthyridine compounds as CK2 inhibitors2024 12,173,003Pyrrolo[3,2-C][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 12,173,001Pyrido[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines as CK2 inhibitors2024 12,168,662Pyrido[4',3':4,5]pyrrolo[2,3-c][2,7]naphthyridines compounds as CK2 inhibitors2024 12,134,617Pyrimido[1'6':1,5]pyrazolo[4,3-c][1,7]naphthyridines as CK2 inhibitors2024 12,129,252Pyrrolo[2,3-c][2,6]naphthyridine-8-carboxylic acids as CK2 inhibitors2024 12,129,254Pyrimido[6',1':2,3]imidazo[4,5-b][1,6]naphthyridine compounds as CK2 inhibitors2024 12,129,260Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agents2024 12,129,259Pyrazino[1',2':1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitors2024 12,129,257Imidazo[1,2-a]pyrazine compounds as CK2 inhibitors2024 12,122,775Substituted pyrido[4,3-e]pyrrolo[1,2-a]pyrazines as CK2 inhibitors2024 12,071,437Pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-2-carboxylic acids as CK2 inhibitors2024 12,024,518Pyrazolo[4,3-C][1,6]naphthyridines as CK2 inhibitors2024 12,018,026Pyrido[4,3-e][1,2,3]triazolo[1,5-a]pyrimidine as CK2 inhibitors2024 12,018,0285-substituted aminopyrazino[2',1':2,3]imidazo[4,5-c][2,7]naphthyridine compounds as CK2 inhibitors2024 12,012,407Pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-3-carboxylic acids as CK2 inhibitors2024 12,012,406Pyrido[4,3-e]pyrrolo[1,2-a]pyrimidine as CK2 inhibitors2024 12,012,414Imidazo[1,5-a]pyrido[4,3-e]pyrimidines as CK2 inhibitors2024 12,006,3175-substituted aminopyrimido [6',1':2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitors2024 11,999,7355-substituted aminopyrimido [6',1':2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitors2024 11,999,736Pyrazino[2',1':2,3]imidazo[4,5-b][1,7]naphthyridines compounds as CK2 inhibitors2024 11,987,581Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-2-carboxylic acids as CK2 inhibitors2024 11,981,676Pyrazolo[4,3-c][2,6]naphthyridines as CK2 inhibitors2024 11,981,675Pyrrolo[3,2-C]quinoline-2,3-dione compounds as CK2 inhibitors2024 11,976,079Pyrazino[1',2':1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitors2024 11,976,080Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agents2024 11,976,070Substituted pyrimido[6aEUR(tm), 1aEUR(tm):2,3]imidazo[4,5-c][1,6]naphthyridines as CK2 inhibitors2024 11,970,499Pyrazolo[1,5-c]pyrimidine compounds as CK2 inhibitors2024 11,970,496Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors2024 11,964,981Substituted pyrimido[4,5-b]indoles as CK2 inhibitors2024 11,964,9755-substituted aminopyrimido[6',1':2,3]imidazo[4,5-c][2,6]naphthyridine compounds as CK2 inhibitors2024 11,964,974Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-3-carboxylic acids as CK2 inhibitors2024 11,964,976Substituted pyrido[3',4':4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors2024 11,958,851Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors2024 11,958,8536-substituted aminopyrazino[2',1':2,3]imidazo[4,5-c][1,7]naphthyridine compounds as CK2 inhibitors2024 11,958,847Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitors2024 11,952,383Aza-podophyllotoxin analogues as potential anti-cancer agents2024 11,952,378Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitors2024 11,945,818Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors2024 11,945,823Substituted pyrrolo[2,3-d]pyrimidines as CK2 inhibitors2024 11,945,820Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 11,945,8215-substituted aminopyrazino[2',1':2,3]imidazo[4,5-C][2,7]naphthyridine compounds as CK2 inhibitors2024 11,939,330Pyrido[3,4-b]indole-6-carboxylic acid compounds as CK2 inhibitors2024 11,938,120Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents2024 11,932,640Pyrrolo[3,4-b]quinoline compounds as antibacterial agents2024 11,932,641Pyrido[4',3':4,5]pyrrolo[3,2-b][1,7]naphthyridine compounds as CK2 inhibitors2024 11,932,642Substituted pyrido[3',4':4,5]pyrrolo[3,2-b][1,6]naphthyridines as CK2 inhibitors2024 11,926,629Pyrido[3',4':4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors2024 11,905,289Pyrido[3',4':4,5]pyrrolo[3,2-C]naphthyridine compounds as CK2 inhibitors2024 11,905,288Pyrido[3'',4'':4', 5']pyrrolo[3',2':4,5]imidazole[1,2-c]pyrimidine compounds as CK2 inhibitors2024 11,905,2905-substituted aminopyrimido[6',1':2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitors2024 11,897,881Substituted pyrido[3,4-b]indole-3-carboxylic acids as CK2 inhibitors2024 11,897,883Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 11,897,859Coumarin compounds as antibacterial agents2024 11,891,377Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 11,891,3955-substituted aminopyrazino[2',1':2,3]imidazo[4,5-C][2,7]naphthyridine compounds as CK2 inhibitors2024 11,891,3903-substituted amino-2-arylpyrrolo[2,3-c]pyridines as CK2 inhibitors2024 11,891,3965-substituted pyrido[3'',4'':4',5']pyrrolo[3',2':4,5]imidazo[1,2-a]pyrazine compounds as CK2 inhibitors2024 11,891,397Pyrido[4',3':4,5]pyrrolo[3,2-c][1,7]naphthyridin-10-one compounds as CK2 inhibitors2024 11,891,362N2,N4-disubstituted pyrimidine-2,4-diamine compounds as antibacterial agents2024 11,891,394Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors2024 11,884,669Pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 11,884,668Substituted pyrido[3',4':4,5]pyrrolo[2,3-c]quinolines as CK2 inhibitors2024 11,884,670Pyrido[4',3':4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitors2024 11,884,631Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agents2024 11,884,667Substituted pyrrolo[2,3-c][2,7]naphthyridines as CK2 inhibitors2024 11,878,978Pyrrolo[2,3-c]quinoline compounds as CK2 inhibitors2024 11,866,4371,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitors2024 11,866,412Acridin-9-one compounds as antibacterial agents2024 11,858,934Substituted pyrido[4',3':5,6]pyrimido[1,2-a]indoles as CK2 inhibitors2024 11,858,893Aza-Podophyllotoxin analogues as potential anti-cancer agents2024 11,858,935Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors2024 11,851,430Pyrido[4,3-B]indole-7-carboxylic acid compounds as CK2 inhibitors2023 11,845,749Substituted pyrido[4',3':5,6]pyrazino[1,2-a]indoles as anticancer agents2023 11,845,743Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitors2023 11,845,746Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents2023 11,820,779Aza-podophyllotoxin analogues as potential anti-cancer agents2023 11,807,6407-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agents2023 11,807,607Aminocarbazole compounds as antibacterial agents2023 11,807,639Pyrrolo[3,4-b]quinoline compounds as antibacterial agents2023 11,802,130Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agents2023 11,802,129Pyrido[3,4-b]indol-1-one compounds as anticancer agents2023 11,780,809Carbazole compounds as antibacterial agents2023 11,780,838Pyrrolo[3,2-b]quinoline compounds as antibacterial agents2023 11,773,093N-(pyrimido[2,3-b]indol-7-yl)acetamide compounds as antibacterial agents2023 11,773,0844-arylamino-2-(6-indolylamino)pyrimidine compounds as antibacterial agents2023 11,773,092Pyrido[3,4-b]indol-1-one compounds as antibacterial agents2023 11,731,970Pyrrolo[2,3-b]quinoline compounds as antibacterial agents2023 11,731,980Furo[3,4-b]quinolone compounds as antibacterial agents2023 11,731,9423-substituted quinolin-2-one compounds as antibacterial agents2023 11,731,939Indole-based chalcone compounds as antibacterial agents2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to UNIV KING FAISAL (102)· patent assignee history

2023–2025Based in SA· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV KING FAISAL	102	2023–2025

Locations

Location	Patents	Span
SA	102	2023–2025